6533b7cffe1ef96bd1258fe3

RESEARCH PRODUCT

Cardioprotective effects of phytopigments via multiple signaling pathways.

Raju Suresh KumarRessin VargheseNatarajan ArumugamAbdulrahman I. AlmansourThomas EfferthC. George Priya DossSiva Ramamoorthy

subject

Cardiotonic AgentsPharmaceutical ScienceAnthraquinonesXanthophyllsBioinformaticsstatAntioxidantsAnthocyaninsDrug DiscoveryMedicineAnimalsHumansClinical efficacyProtein kinase BPharmacologyFlavonoidsbusiness.industryNF-kappa BAMPKCarotenoidsClinical trialComplementary and alternative medicineCardiotoxicitiesCardiac hypertrophyMolecular MedicineSignal transductionbusinessSignal Transduction

description

Abstract Background Cardiovascular diseases (CVDs) are among the deadliest non-communicable diseases, and millions of dollars are spent every year to combat CVDs. Unfortunately, the multifactorial etiology of CVDs complicates the development of efficient therapeutics. Interestingly, phytopigments show significant pleiotropic cardioprotective effects both in vitro and in vivo. Purpose This review gives an overview of the cardioprotective effects of phytopigments based on in vitro and in vivo studies as well as clinical trials. Methods A literature-based survey was performed to collect the available data on cardioprotective activities of phytopigments via electronic search engines such as PubMed, Google Scholar, and Scopus. Results Different classes of phytopigments such as carotenoids, xanthophylls, flavonoids, anthocyanins, anthraquinones alleviate major CVDs (e.g., cardiac hypertrophy, atherosclerosis, hypertension, cardiotoxicities) via acting on signaling pathways related to AMPK, NF-κB, NRF2, PPARs, AKT, TLRs, MAPK, JAK/STAT, NLRP3, TNF-α, and RA. Conclusion Phytopigments represent promising candidates to develop novel and effective CVD therapeutics. More randomized, placebo-controlled clinical studies are recommended to establish the clinical efficacy of phytopigments.

10.1016/j.phymed.2021.153859https://pubmed.ncbi.nlm.nih.gov/34856476